Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Acute Kidney Injury | Research article

Preventing acute kidney injury in high-risk patients by temporarily discontinuing medication – an observational study in general practice

Authors: Suzanne J. Faber, Nynke D. Scherpbier, Hans J. G. Peters, Annemarie A. Uijen

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

Elderly, patients with chronic kidney disease (CKD) and patients with heart failure who continue using renin-angiotensin-aldosterone-system (RAAS) inhibitors, diuretics, or non-steroidal-anti-inflammatory drugs (NSAIDs) during times of fluid loss have a high risk of developing complications like acute kidney injury (AKI). The aim of this study was to assess how often advice to discontinue high-risk medication was offered to high-risk patients consulting the general practitioner (GP) with increased fluid loss. Furthermore, we assessed the number and nature of the complications that occurred after GP consultation.

Methods

We performed a cross-sectional study with patients from seven Dutch general practices participating in the Family Medicine Network between 1 and 6-2013 and 1-7-2018. We included patients who used RAAS-inhibitors, diuretics, or NSAIDs, and had at least one of the following risk factors: age ≥ 70 years, CKD, or heart failure. From this population, we selected patients with a ‘dehydration-risk’ episode (vomiting, diarrhoea, fever, chills, or gastrointestinal infection). We manually checked their electronic patient files and assessed the percentage of episodes in which advice to discontinue the high-risk medication was offered and whether a complication occurred in 3 months after the ‘dehydration-risk’ episode.

Results

We included 3607 high-risk patients from a total of 44.675 patients (8.1%). We found that patients were advised to discontinue the high-risk medication in 38 (4.6%) of 816 ‘dehydration-risk’ episodes. In 59 of 816 episodes (7.1%) complications (mainly AKI) occurred.

Conclusions

Dutch GPs do not frequently advise high-risk patients to discontinue high-risk medication during ‘dehydration-risk’ episodes. Complications occur frequently. Timely discontinuation of high-risk medication needs attention.
Literature
2.
go back to reference Canavan A, Arant BS Jr. Diagnosis and management of dehydration in children. Am Fam Physician. 2009;80(7):692–6.PubMed Canavan A, Arant BS Jr. Diagnosis and management of dehydration in children. Am Fam Physician. 2009;80(7):692–6.PubMed
3.
go back to reference Goulet ED. Dehydration and endurance performance in competitive athletes. Nutr Rev. 2012;70(Suppl 2):S132–6.CrossRef Goulet ED. Dehydration and endurance performance in competitive athletes. Nutr Rev. 2012;70(Suppl 2):S132–6.CrossRef
4.
go back to reference National Clinical Guideline C. National Institute for Health and Clinical Excellence: Guidance. Acute Kidney Injury: Prevention, Detection and Management Up to the Point of Renal Replacement Therapy. London: Royal College of Physicians (UK) National Clinical Guideline Centre; 2013. National Clinical Guideline C. National Institute for Health and Clinical Excellence: Guidance. Acute Kidney Injury: Prevention, Detection and Management Up to the Point of Renal Replacement Therapy. London: Royal College of Physicians (UK) National Clinical Guideline Centre; 2013.
5.
go back to reference Kreimeier U. Pathophysiology of fluid imbalance. Crit Care. 2000;4(Suppl 2):S3–7.CrossRef Kreimeier U. Pathophysiology of fluid imbalance. Crit Care. 2000;4(Suppl 2):S3–7.CrossRef
6.
go back to reference Scherpbier ND, de Grauw WJ, Wetzels JF, Vervoort GM. Acute renal failure due to RAAS-inhibitors combined with dehydration. Ned Tijdschr Geneeskd. 2010;154:A1548.PubMed Scherpbier ND, de Grauw WJ, Wetzels JF, Vervoort GM. Acute renal failure due to RAAS-inhibitors combined with dehydration. Ned Tijdschr Geneeskd. 2010;154:A1548.PubMed
7.
go back to reference van Geffen K. Nieren en medicijnen. In: Nierstichting; 2016. p. 7. van Geffen K. Nieren en medicijnen. In: Nierstichting; 2016. p. 7.
9.
go back to reference Sraer JD, Kanfer A, Rondeau E, Lacave R. Role of the renin-angiotensin system in the regulation of glomerular filtration. J Cardiovasc Pharmacol. 1989;14(Suppl 4):S21–5.CrossRef Sraer JD, Kanfer A, Rondeau E, Lacave R. Role of the renin-angiotensin system in the regulation of glomerular filtration. J Cardiovasc Pharmacol. 1989;14(Suppl 4):S21–5.CrossRef
10.
go back to reference Burnier M. Blockade of the renin-angiotensin system and the risk of acute kidney injury. J Clin Hypertens (Greenwich). 2016;18(6):512–3.CrossRef Burnier M. Blockade of the renin-angiotensin system and the risk of acute kidney injury. J Clin Hypertens (Greenwich). 2016;18(6):512–3.CrossRef
11.
go back to reference Dunn MJ. Prostaglandin I2 and the kidney. Archives des maladies du coeur et des vaisseaux, vol. 82; 1989. p. 27–31. Dunn MJ. Prostaglandin I2 and the kidney. Archives des maladies du coeur et des vaisseaux, vol. 82; 1989. p. 27–31.
13.
go back to reference Che ML, Yan YC, Zhang Y, Gu Y, Wang NS, Chen N, et al. Analysis of drug-induced acute renal failure in Shanghai. Zhonghua Yi Xue Za Zhi. 2009;89(11):744–9.PubMed Che ML, Yan YC, Zhang Y, Gu Y, Wang NS, Chen N, et al. Analysis of drug-induced acute renal failure in Shanghai. Zhonghua Yi Xue Za Zhi. 2009;89(11):744–9.PubMed
14.
go back to reference McMurray J, Matthews DM. Consequences of fluid loss in patients treated with ACE inhibitors. Postgrad Med J. 1987;63(739):385–7.CrossRef McMurray J, Matthews DM. Consequences of fluid loss in patients treated with ACE inhibitors. Postgrad Med J. 1987;63(739):385–7.CrossRef
15.
go back to reference Stirling C, Houston J, Robertson S, Boyle J, Allan A, Norrie J, et al. Diarrhoea, vomiting and ACE inhibitors:--an important cause of acute renal failure. J Hum Hypertens. 2003;17(6):419–23.CrossRef Stirling C, Houston J, Robertson S, Boyle J, Allan A, Norrie J, et al. Diarrhoea, vomiting and ACE inhibitors:--an important cause of acute renal failure. J Hum Hypertens. 2003;17(6):419–23.CrossRef
16.
go back to reference Baraldi A, Ballestri M, Rapana R, Lucchi L, Borella P, Leonelli M, et al. Acute renal failure of medical type in an elderly population. Nephrol Dial Transplant. 1998;13(Suppl 7):25–9.CrossRef Baraldi A, Ballestri M, Rapana R, Lucchi L, Borella P, Leonelli M, et al. Acute renal failure of medical type in an elderly population. Nephrol Dial Transplant. 1998;13(Suppl 7):25–9.CrossRef
17.
go back to reference Wynckel A, Ebikili B, Melin JP, Randoux C, Lavaud S, Chanard J. Long-term follow-up of acute renal failure caused by angiotensin converting enzyme inhibitors. Am J Hypertens. 1998;11(9):1080–6.CrossRef Wynckel A, Ebikili B, Melin JP, Randoux C, Lavaud S, Chanard J. Long-term follow-up of acute renal failure caused by angiotensin converting enzyme inhibitors. Am J Hypertens. 1998;11(9):1080–6.CrossRef
18.
go back to reference Chaumont M, Pourcelet A, van Nuffelen M, Racape J, Leeman M, Hougardy JM. Acute kidney injury in elderly patients with chronic kidney disease: do angiotensin-converting enzyme inhibitors carry a risk? J Clin Hypertens (Greenwich). 2016;18(6):514–21.CrossRef Chaumont M, Pourcelet A, van Nuffelen M, Racape J, Leeman M, Hougardy JM. Acute kidney injury in elderly patients with chronic kidney disease: do angiotensin-converting enzyme inhibitors carry a risk? J Clin Hypertens (Greenwich). 2016;18(6):514–21.CrossRef
19.
go back to reference Belo J, Bos M, Brühl F, Lemmen W, Pijpers M, van den Donk M, et al. NHG-Standaard Acute diarree (derde herziening). Huisarts Wet. 2014;57:462–71. Belo J, Bos M, Brühl F, Lemmen W, Pijpers M, van den Donk M, et al. NHG-Standaard Acute diarree (derde herziening). Huisarts Wet. 2014;57:462–71.
20.
24.
go back to reference KDOQI Clinical Practice Guideline for Diabetes and CKD. 2012 Update. Am J Kidney Dis. 2012;60(5):850–86.CrossRef KDOQI Clinical Practice Guideline for Diabetes and CKD. 2012 Update. Am J Kidney Dis. 2012;60(5):850–86.CrossRef
25.
go back to reference Ahmed A. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine? J Am Geriatr Soc. 2002;50:1297–30.CrossRef Ahmed A. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine? J Am Geriatr Soc. 2002;50:1297–30.CrossRef
26.
go back to reference Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–c84.PubMed Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–c84.PubMed
29.
go back to reference Centraal Bureau voor de Statistiek Bevolking; geslacht, leeftijd en burgerlijke staat 1 januari 2017. Centraal Bureau voor de Statistiek Bevolking; geslacht, leeftijd en burgerlijke staat 1 januari 2017.
Metadata
Title
Preventing acute kidney injury in high-risk patients by temporarily discontinuing medication – an observational study in general practice
Authors
Suzanne J. Faber
Nynke D. Scherpbier
Hans J. G. Peters
Annemarie A. Uijen
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1636-z

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue